Onconetix (ONCO) Net Income towards Common Stockholders (2023 - 2025)
Historic Net Income towards Common Stockholders for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$8.8 million.
- Onconetix's Net Income towards Common Stockholders fell 12949.5% to -$8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.8 million, marking a year-over-year increase of 146.92%. This contributed to the annual value of -$58.9 million for FY2024, which is 5743.89% down from last year.
- As of Q3 2025, Onconetix's Net Income towards Common Stockholders stood at -$8.8 million, which was down 12949.5% from -$2.7 million recorded in Q2 2025.
- In the past 5 years, Onconetix's Net Income towards Common Stockholders ranged from a high of -$2.7 million in Q2 2025 and a low of -$29.6 million during Q4 2024
- Moreover, its 3-year median value for Net Income towards Common Stockholders was -$8.8 million (2025), whereas its average is -$10.7 million.
- Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 29058.53% in 2024, then soared by 8112.11% in 2025.
- Onconetix's Net Income towards Common Stockholders (Quarter) stood at -$22.4 million in 2023, then plummeted by 32.63% to -$29.6 million in 2024, then surged by 70.37% to -$8.8 million in 2025.
- Its last three reported values are -$8.8 million in Q3 2025, -$2.7 million for Q2 2025, and -$9.7 million during Q1 2025.